Patents-Review.com
ClassID:

116374 ⎘

C12Y301/04001 - CPC Classification

Classification description:

Hydrolases acting on ester bonds (3.1); Phosphoric diester hydrolases (3.1.4) Phosphodiesterase I (3.1.4.1)

Recent Application in this class:
#1
20260041742
2026-02-12

METHOD AND COMPOSITIONS FOR TREATMENT, AMELIORATION, AND/OR PREVENTION OF DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS (DISH)

 #2
20260022356
2026-01-22

NPP1 Fusion Proteins

 #3
20260021166
2026-01-22

AGENT FOR IMPROVING INTESTINAL FLORA

 #4
20250388882
2025-12-25

COMPOSITIONS FOR TREATING ECTOPIC CALCIFICATION DISORDERS, AND METHODS USING SAME

 #5
20250295733
2025-09-25

Compositions for Treating Pathological Calcification Conditions, and Methods Using Same

 #6
20250230423
2025-07-17

ENPP1 POLYPEPTIDES AND METHODS OF USING SAME

 #7
20250197909
2025-06-19

SUBMERGED FERMENTATION PROCESS

 #8
20250043341
2025-02-06

Method of Amplifying Circular DNA

 #9
20250019677
2025-01-16

METHODS OF IMPROVING CARDIOVASCULAR FUNCTION AND TREATING CARDIOVASCULAR DISEASE USING A RECOMBINANT ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE (NPP1)

 #10
20240181021
2024-06-06

Treatment of ENPP1 Deficiency and ABCC6 Deficiency

 #11
20240148907
2024-05-09

LIVER SPECIFIC PRODUCTION OF ENPP1 OR ENPP3

 #12
20240016951
2024-01-18

COMPOSITIONS AND METHODS FOR TREATING ALLOGRAFT VASCULOPATHY, MOYAMOYA DISEASE, MOYAMOYA SYNDROME AND INTIMAL PROLIFERATION

 #13
20230313158
2023-10-05

SOLUBLE ENPP1 PROTEINS AND USES THEREOF

 #14
20230227800
2023-07-20

Compositions for treating ectopic calcification disorders, and methods using same

 #15
20230129977
2023-04-27

NPP1 FUSION PROTEINS

 #16
20220195402
2022-06-23

ENPP1 POLYPEPTIDES AND METHODS OF USING SAME

 #17
20220152163
2022-05-19

Compositions and Methods for Treating Pathological Calcification and Ossification

 #18
20220133854
2022-05-05

Compositions for treating pathological calcification conditions, and methods using same

 #19
20210401950
2021-12-30

COMPOSITIONS FOR TREATING PATHOLOGICAL CALCIFICATION CONDITIONS, AND METHODS USING SAME

 #20
20210324345
2021-10-21

Recombinant Microorganism for Producing 2,3-Butanediol and a Method of Production of 2,3-Butanediol

 #21
20210301268
2021-09-30

NPP1 FUSION PROTEINS

 #22
20210032610
2021-02-04

Compositions for Treating Ectopic Calcification Disorders, and Methods Using Same

 #23
20200306349
2020-10-01

Methods of treating myointimal proliferation

 #24
20200263153
2020-08-20

Methods of improving cardiovascular function and treating cardiovascular disease using a recombinant ectonucleotide pyrophosphatase phosphodiesterase (NPP1)

 #25
20200237882
2020-07-30

Compositions and methods for treating pathological calcification and ossification

 #26
20200237865
2020-07-30

Methods for treating pseudoxanthoma elasticum (PXE)

 #27
20200138905
2020-05-07

Compositions for treating pathological calcification conditions, and methods using same

 #28
20190282703
2019-09-19

ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE (ENPP) CONJUGATES AND USES THEREOF

 #29
20190276883
2019-09-12

Method of amplifying circular DNA

 #30
20190231849
2019-08-01

Compositions for treating pathological calcification conditions, and methods using same

 #31
20190167768
2019-06-06

Compositions and methods for treating nonsteroidal anti-inflammatory drug (NSAID) associated coagulopathy, thrombocytopenia, glanzmann's thrombasthenia, and/or thrombosis

 #32
20190100784
2019-04-04

RNA analysis by total hydrolysis and quantification of released nucleosides

 #33
20180371434
2018-12-27

Compositions for Treating Ectopic Calcification Disorders, and Methods Using Same

 #34
20180318401
2018-11-08

Compositions and methods for treating pathological calcification and ossification

 #35
20180318400
2018-11-08

Methods of treating tissue calcification

 #36
20180252713
2018-09-06

Methods and compositions for protein purification and enzyme reaction

 #37
20180169192
2018-06-21

Compositions and methods for treating platelet storage pool deficiency, gray platelet syndrome and quebec platelet disorder

 #38
20180148795
2018-05-31

Methods of prostate cancer prognosis

 #39
20180064786
2018-03-08

Compositions for treating pathological calcification conditions, and methods using same

 #40
20180057821
2018-03-01

Compositions for treating pathological calcification conditions, and methods using same

 #41
20180057820
2018-03-01

Compositions for treating pathological calcification conditions, methods, and host cells using the same

 #42
20170354719
2017-12-14

Compositions and methods for treating pathological calcification and ossification

 #43
20170340714
2017-11-30

Compositions for treating pathological calcification conditions, and methods using same

 #44
20170340713
2017-11-30

Compositions for treating pathological calcification conditions, and methods using same

 #45
20170333533
2017-11-23

Compositions and Methods for Treating Pathological Calcification and Ossification

 #46
20170274054
2017-09-28

Compositions and methods for treating hemophilia

 #47
20170252414
2017-09-07

Compositions and methods for treating pathological calcification and ossification

 #48
20170145393
2017-05-25

NPP1 FUSION PROTEINS

 #49
20170073778
2017-03-16

Risk scores based on human phosphodiesterase 4D variant 7 expression

 #50
20150359858
2015-12-17

Compositions and methods for treating pathological calcification and ossification

 #51
20150024460
2015-01-22

NPP1 FUSION PROTEINS

 #52
20140377859
2014-12-25

NPP1 fusion proteins

 #53
14358166
2017-05-09

Compositions and methods for modulating coagulation